Merkley Lands Pfizer's Lipitor

Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.

NEW YORK-Pfizer has selected Merkley Newman Harty to handle creative duties on Lipitor, an anti-cholesteral drug previously handled by Bates Worldwide, sources said. Billings are estimated at $70 million.

In its third Pfizer pitch in 17 months, Merkley, here, beat Pfizer roster shops Cline, Davis & Mann and Gotham, as well as Kirshenbaum Bond & Partners and Messner Vetere Berger McNamee Schmetterer/Euro RSCG, all in New York.

Merkley took an integrated approach, offering everything from traditional advertising to direct and interactive marketing, according to sources.



AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in